Video: Novel Targeted Antioxidants Therapy Takes Aim at Breast Cancer
Balaraman Kalyanaraman, PhD, Harry R. & Angeline E. Quadracci Professor in Parkinson's Research and chairman of biophysics, is the principal investigator. He received a five-year, $1.5 million grant from the National Institutes of Health's Cancer Institute to develop targeted therapies to enhance the killing power of anti-cancer while simultaneously protecting the heart from the drug's toxic side effects.
"One of the challenges of cancer therapy is to kill tumor cells while simultaneously minimizing the drug's side effects", said Dr. Kalyanaraman, "Novel targeted antioxidant therapy is doing just that."
Watch Video
News Releases:
Novel Targeted Antioxidants Take Aim at Enhancing Breast Cancer Therapy, While Reducing Side Effects
Contact Information:
For additional information, please contact Media Relations at (414) 955-4700 or via email at mcwmediarelations@mcw.edu
May 16 - Mary Horowitz, MD, MS, Robert A. Uihlein, Jr. Chair in Hematologic Research, Professor of Medicine and Chief of Hematology and Oncology, was inducted into the Association of American Physicians (AAP) at the group’s annual meeting in Chicago.
May 16 - The 2013 WBCS, Inc. Showhouse for a Cure features a beautiful home on Newberry Boulevard in Milwaukee, named one of America’s “Great Streets” by the American Planning Association.
May 16 - The Bead&Button Show, the country’s largest consumer bead show, will be held in Milwaukee June 7-9. The show will feature the Bead Artists Against Breast Cancer silent and live auctions of beads, jewelry, books, and supplies, with one hundred percent of the funds raised donated to breast cancer research at the Medical College of Wisconsin.
May 15 - Raise a Glass to Hope, a preview party for the 2013 Wisconsin Breast Cancer Showhouse, organized by WBCS, Inc., will be held Friday, May 31, 6 p.m., at 2228 E. Newberry Blvd., Milwaukee.
May 15 - The National Biomedical Electron Paramagnetic Resonance (EPR) Center at the Medical College of Wisconsin (MCW) has received a five-year, $6 million renewal grant from the National Institute of Health’s National Institute of Biomedical Imaging and Bioengineering. The EPR Center was established in 1976, and has been continuously funded since. It is classified as a Biomedical Technology Resource Center, and is one of eight federally-designated research centers at MCW.
May 13 - James S. Hyde, PhD, the James S. Hyde Professor of Biophysics and Director of the National Biomedical EPR Center at MCW, is one of this year’s Eureka Awards presented by the Milwaukee Business Journal. Milwaukee Business Journal
May 15 - The 2013 WBCS, Inc. Showhouse for a Cure features a beautiful home on Newberry Boulevard in Milwaukee, named one of America’s “Great Streets” by the American Planning Association.
May 13 - The National Biomedical Electron Paramagnetic Resonance (EPR) Center at the Medical College of Wisconsin (MCW) has received a five-year, $6 million renewal grant from the National Institute of Health’s National Institute of Biomedical Imaging and Bioengineering.
May 14 - The Triumph Fund is hosting a dinner to support the MCW Cancer Center Clinical Trials Office at the Wisconsin Club on Wednesday, June 26. Appetizers begin at 6 p.m., followed by a dinner featuring Wisconsin wines. James P. Thomas, MD, PhD, Medical Director of the MCW Clinical Trials Office and Professor of Medicine (Hematology and Oncology), will share a presentation about the importance of clinical trials and discuss the clinical research being conducted at MCW.
May 7 - For the sixth consecutive year, Froedtert & The Medical College of Wisconsin will be joining with Fox 6 TV and the Milwaukee Brewers to sponsor free prostate screening tests on May 29 at Miller Park. Dr. William See explained the importance for men to be screened for prostate cancer. WauwatosaNOW